Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

257 ta ish

Ish: Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

  1. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

    Juhani Knuuti, William Wijns, Antti Saraste +83

    MaqolaOchiq kirish201915 iqtibos
    ABI

  2. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    Milton Packer, Stefan D. Anker, Javed Butler +36

    Maqola20208 iqtibos
    ABI

  3. General Cardiovascular Risk Profile for Use in Primary Care

    Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina +4

    MaqolaOchiq kirish20086 iqtibos
    ABI

  4. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

    Authors/Task Force Members:, Joep Perk, Guy De Backer +82

    MaqolaOchiq kirish20126 iqtibos
    ABI

  5. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi +35

    Maqola20196 iqtibos
    ABI

  6. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

    John J.V. McMurray, Milton Packer, Akshay S. Desai +8

    Maqola20146 iqtibos
    ABI

  7. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants

    Yuan Lu, Kaveh Hajifathalian, Majid Ezzati +3

    MaqolaOchiq kirish20135 iqtibos
    ABI

  8. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

    Faı̈ez Zannad, John J.V. McMurray, Henry Krum +6

    Maqola20105 iqtibos
    ABI

  9. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

    Dena Ettehad, Connor A. Emdin, Amit Kiran +6

    Sharh maqola20154 iqtibos
    ABI

  10. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

    Sarah Lewington, Robert Clarke, Nawab Qizilbash +2

    Sharh maqola20024 iqtibos
    ABI

  11. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

    Biykem Bozkurt, David Aguilar, Anita Deswal +9

    Sharh maqola20164 iqtibos
    ABI

  12. Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults

    Gerald S. Berenson, Sathanur R. Srinivasan, Weihang Bao +3

    MaqolaOchiq kirish19983 iqtibos
    ABI

  13. Effects of blood pressure-lowering on outcome incidence in hypertension

    Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti

    Sharh maqola20153 iqtibos
    ABI

  14. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis

    Chenhan Ma, Alison Avenell, Mark J Bolland +6

    Sharh maqolaOchiq kirish20173 iqtibos
    ABI

  15. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

    Bryan Williams, Thomas M. MacDonald, S. V. Morant +10

    MaqolaOchiq kirish20153 iqtibos
    ABI

  16. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

    Tiffany M. Powell‐Wiley, Paul Poirier, Lora E. Burke +8

    Sharh maqola20213 iqtibos
    ABI

  17. Obesity and the Obesity Paradox in Heart Failure

    Tamara B. Horwich, Gregg C. Fonarow, Adrienne L. Clark

    Sharh maqola20183 iqtibos
    ABI

  18. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

    Renate B. Schnabel, Xiaoyan Yin, Philimon Gona +12

    Maqola20153 iqtibos
    ABI

  19. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

    The Look AHEAD Research Group

    Maqola20133 iqtibos
    ABI

  20. Cardiac PET Imaging for the Detection and Monitoring of Coronary Artery Disease and Microvascular Health

    Thomas H. Schindler, Heinrich R. Schelbert, Alessandra Quercioli +1

    Sharh maqola20103 iqtibos
    ABI

  21. Cardiovascular Risk After Bariatric Surgery for Obesity

    John A. Batsis, Michael G. Sarr, Maria L. Collazo–Clavell +4

    Sharh maqola20083 iqtibos
    ABI

  22. Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

    David S Wald, Malcolm Law, Joan K. Morris +2

    Sharh maqola20093 iqtibos
    ABI

  23. Effect of Aging and Physical Activity on Left Ventricular Compliance

    Armin Arbab‐Zadeh, Erika Dijk, Anand Prasad +6

    Maqola20043 iqtibos
    ABI

  24. The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management

    Rajeev K. Pathak, Rajiv Mahajan, Dennis H. Lau +1

    Sharh maqola20143 iqtibos
    ABI

  25. Clinical Evaluation of Geriatric Outpatients with Suspected Heart Failure: Value of Symptoms, Signs, and Additional Tests

    Irène Oudejans, Arend Mosterd, Johanna A. Bloemen +6

    Maqola20113 iqtibos
    ABI